MKGCX
Price
$31.37
Change
-$0.30 (-0.95%)
Updated
Nov 18 closing price
Net Assets
513.11M
RWICX
Price
$74.06
Change
-$0.67 (-0.90%)
Updated
Nov 18 closing price
Net Assets
139.93B
Interact to see
Advertisement

MKGCX vs RWICX

Header iconMKGCX vs RWICX Comparison
Open Charts MKGCX vs RWICXBanner chart's image
BlackRock Advantage Global K
Price$31.37
Change-$0.30 (-0.95%)
VolumeN/A
Net Assets513.11M
American Funds Capital World Gr&Inc R3
Price$74.06
Change-$0.67 (-0.90%)
VolumeN/A
Net Assets139.93B
MKGCX vs RWICX Comparison Chart in %
View a ticker or compare two or three
VS
MKGCX vs. RWICX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKGCX is a Hold and RWICX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 140B vs. MKGCX (513M). RWICX (1.11) and MKGCX (1.10) have matching dividends . MKGCX was incepted earlier than RWICX: MKGCX (8 years) vs RWICX (23 years). RWICX (1.06) is less costly to investors than MKGCX (0.82). MKGCX is a more actively managed with annual turnover of: 160.00 vs. RWICX (27.00). RWICX has a lower initial minimum investment than MKGCX: RWICX (250) vs MKGCX (5000000). RWICX annual gain was more profitable for investors over the last year : 11.78 vs. MKGCX (4.92). RWICX return over 5 years is better than : 39.85 vs. MKGCX (34.57).
MKGCXRWICXMKGCX / RWICX
Total Expense Ratio0.661.0662%
Annual Report Gross Expense Ratio0.821.0677%
Fund Existence8 years23 years-
Gain YTD18.96118.544102%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets513M140B0%
Annual Yield % from dividends1.101.1199%
Returns for 1 year4.9211.7842%
Returns for 3 years52.8549.34107%
Returns for 5 years34.5739.8587%
Returns for 10 yearsN/A71.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNDA5.340.94
+21.36%
Vanda Pharmaceuticals
GRCE3.160.16
+5.33%
Grace Therapeutics Inc
PATH13.740.22
+1.63%
UiPath
FTAIN25.690.18
+0.73%
FTAI Aviation Ltd
COLL45.31-0.03
-0.07%
Collegium Pharmaceutical